Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    HT Staff

    News

    Host cell type may impact malaria treatment

    Author:
    HT Staff
    Publish date: June 8, 2015

    Image by Peter H.

    • Read More

    News

    BCL-2 inhibitor shows potential for treating MM

    Author:
    HT Staff
    Publish date: June 7, 2015

    to an attendee at ASCO 2015 © ASCO/Zach Boyden-Holmes CHICAGO—A BCL-2 inhibitor that has shown activity in patients with chronic and acute...

    • Read More

    News

    Blood test screens for many viruses simultaneously

    Author:
    HT Staff
    Publish date: June 5, 2015

    Photo by Максим Кукушкин Scientists have reported that a new test can screen patients for current and past infection with more than 1000 viral...

    • Read More

    News

    Resolution draws attention to sickle cell trait

    Author:
    HT Staff
    Publish date: June 5, 2015

    and a normal one Image by Betty Pace Two members of the US House of Representatives have introduced a resolution calling for expanded government...

    • Read More

    News

    Nutrition source could improve platinum-based nanodrugs

    Author:
    HT Staff
    Publish date: June 4, 2015

    A parenteral nutrition source can reduce the toxicity and increase the bioavailability of platinum-based anticancer nanodrugs, according to...

    • Read More

    News

    Biochemist Irwin Rose dies at 88

    Author:
    HT Staff
    Publish date: June 4, 2015

    Photo courtesy of UCI Biochemist and Nobel laureate Irwin “Ernie” Rose, PhD, has passed away at the age of 88. Dr Rose and colleagues from...

    • Read More

    News

    Single agent can treat resistant MM

    Author:
    HT Staff
    Publish date: June 3, 2015

    © ASCO/Todd Buchanan CHICAGO—The anti-CD38 monoclonal antibody daratumumab can be effective as a stand-alone therapy for some heavily pretreated...

    • Read More

    News

    Cancer survivors mirror spouses’ moods

    Author:
    HT Staff
    Publish date: June 3, 2015

    chemotherapy Photo by Rhoda Baer Cancer survivors’ moods are impacted—both positively and negatively—by their spouses’ moods, according to...

    • Read More

    News

    Scientists uncover structure of TOR complex 2

    Author:
    HT Staff
    Publish date: June 3, 2015

    Photo courtesy of University of Geneva A group of researchers has developed a new tool to study the structure and function of target of rapamycin...

    • Read More

    News

    CDS systems often can’t tell if imaging is appropriate

    Author:
    HT Staff
    Publish date: June 3, 2015

    Photo courtesy of NIH Tools that help physicians decide whether to use diagnostic imaging can help reduce the use of unnecessary tests. But new...

    • Read More

    News

    Drug prolongs PFS in indolent, refractory NHL

    Author:
    HT Staff
    Publish date: June 2, 2015

    the 2015 ASCO Annual Meeting CHICAGO—Adding obinutuzumab to treatment with bendamustine improves progression-free survival (PFS) in patients with...

    • Read More

    News

    Newer anticoagulants may not be best for elderly, study shows

    Author:
    HT Staff
    Publish date: June 2, 2015

    A meta-analysis of 92,816 people taking anticoagulants has shown that the risk of gastrointestinal (GI) bleeding related to the newer oral...

    • Read More

    News

    Breastfeeding may lower risk of ALL

    Author:
    HT Staff
    Publish date: June 2, 2015

    Photo by Petr Kratochvil Breastfeeding a child may reduce his risk of developing acute lymphoblastic leukemia (ALL) but perhaps not acute myeloid...

    • Read More

    News

    Inhibitor may fulfill unmet need in MF

    Author:
    HT Staff
    Publish date: June 1, 2015

    © ASCO/Zach Boyden-Holmes CHICAGO—The JAK2/FLT3 inhibitor pacritinib may fulfill an unmet need in the treatment of myelofibrosis (MF), according...

    • Read More

    News

    Drug improves upon standard therapy for relapsed CLL/SLL, speaker says

    Author:
    HT Staff
    Publish date: May 31, 2015

    Chanan-Khan, MD © ASCO/Zach Boyden-Holmes CHICAGO—Interim results of the phase 3 HELIOS trial suggest that adding ibrutinib to treatment with...

    • Read More

    Pages

    • « first
    • …
    • 174
    • 175
    • 176
    • 177
    • 178
    • 179
    • 180
    • 181
    • 182
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery